key: cord-0988986-u16hi1ej authors: Peahl, Alex F.; Smith, Roger D.; Moniz, Michelle H. title: Prenatal Care Redesign: Creating Flexible Maternity Care Models Through Virtual Care date: 2020-05-17 journal: Am J Obstet Gynecol DOI: 10.1016/j.ajog.2020.05.029 sha: 19e4fa1af4ad625fa185c6a27a2eb650f3c94eb8 doc_id: 988986 cord_uid: u16hi1ej Abstract: Each year, over 98% of the almost 4 million pregnant patients in the United States receive prenatal care—a crucial preventive service to improve outcomes for moms and babies. National guidelines currently recommend 12-14 in-person prenatal visits, a schedule unchanged since 1930. In scrutinizing the standard prenatal visit schedule, it quickly becomes clear that prenatal care is overdue for a redesign. We have strong evidence of the benefit of many prenatal services, like screening for gestational diabetes and maternal vaccination. Yet how to deliver these services is much less clear. Studies of prenatal services consistently demonstrate such care can be delivered in fewer than 14 visits, and that we do not need to provide all maternity services in person. Telemedicine has emerged as a promising care delivery option for patients seeking greater flexibility, and early trials leveraging virtual care and remote monitoring have shown positive maternal and fetal outcomes with high patient satisfaction. Our institution has worked for the past year on a new prenatal care pathway. Our initial work assessed the literature, elicited patient perspectives, and captured the insights of experts in patient-centered care delivery. Two key principles emerged to inform prenatal care redesign: 1) design care delivery around essential services, using in-person care for services that cannot be delivered remotely and offering video visits for other essential services; and 2) create flexible services for anticipatory guidance and psychosocial support that allow patients to tailor support to meet their needs through opt-in programs. The rise of COVID-19 prompted us to extend this early work and rapidly implement a redesigned prenatal care pathway. In this paper, we outline our experience rapidly transitioning prenatal care to a new model with 4 in-person visits, 1 ultrasound visit, and 4 virtual visits (the 4-1-4 prenatal plan). We then explore how lessons from this implementation can inform patient-centered prenatal care redesign during and beyond the COVID-19 pandemic. Disclosure: None of the authors report any conflicts of interest. Funding: Michelle Moniz is supported by the Agency for Healthcare Research and Quality 15 (AHRQ), grant #K08 HS025465. The AHRQ played no role in the design and conduct of the 16 study; collection, management, analysis, and interpretation of the data; preparation, review, or 17 approval of the manuscript; or the decision to submit the manuscript for publication . 18 19 20 21 22 23 24 25 26 27 28 29 30 47 Each year, over 98% of the almost 4 million pregnant patients in the United States receive 48 prenatal care-a crucial preventive service to improve outcomes for moms and babies. National 49 guidelines currently recommend 12-14 in-person prenatal visits, a schedule unchanged since 50 1930. In scrutinizing the standard prenatal visit schedule, it quickly becomes clear that prenatal 51 care is overdue for a redesign. We have strong evidence of the benefit of many prenatal 52 services, like screening for gestational diabetes and maternal vaccination. Yet how to deliver 53 these services is much less clear. Studies of prenatal services consistently demonstrate such 54 care can be delivered in fewer than 14 visits, and that we do not need to provide all maternity 55 services in person. Telemedicine has emerged as a promising care delivery option for patients 56 seeking greater flexibility, and early trials leveraging virtual care and remote monitoring have 57 shown positive maternal and fetal outcomes with high patient satisfaction. Our institution has worked for the past year on a new prenatal care pathway. Our initial work 59 assessed the literature, elicited patient perspectives, and captured the insights of experts in 60 patient-centered care delivery. Two key principles emerged to inform prenatal care redesign: 1) 61 design care delivery around essential services, using in-person care for services that cannot 62 be delivered remotely and offering video visits for other essential services; and 2) create 63 flexible services for anticipatory guidance and psychosocial support that allow patients to 64 tailor support to meet their needs through opt-in programs. The rise of COVID-19 prompted us 65 to extend this early work and rapidly implement a redesigned prenatal care pathway. In this 66 paper, we outline our experience rapidly transitioning prenatal care to a new model with 4 in-67 person visits, 1 ultrasound visit, and 4 virtual visits (the 4-1-4 prenatal plan). We then explore 68 how lessons from this implementation can inform patient-centered prenatal care redesign during 69 and beyond the COVID-19 pandemic. Over the past year, we have planned to create a more flexible, patient-centered prenatal care 102 pathway for our 4000 patients served by over 150 maternity care providers at 12 ambulatory 103 care sites. We first assembled a multi-stakeholder team, including experts in medical care 104 (obstetricians, maternal fetal medicine specialists, family physicians, certified nurse midwives, 105 nurses); information technology (electronic health record architects, virtual care project 106 managers); and administration (coders/billers, hospital administrators). The AGREE-II criteria 107 for practice guidelines, 9 a standardized international checklist for assessing practice guideline 108 quality, informed our efforts to elicit interprofessional perspectives, draw on existing evidence, 109 and optimize guidelines for implementation (Appendix A.1). Based on our systematic literature reviews, 3 survey work with patients, 6 and consultation with 112 national experts in patient-centered care delivery, we identified two overarching principles to With the COVID-19 pandemic creating the need to limit outpatient care to "urgent" visits, we 121 convened our team to rapidly revise the standard outpatient prenatal care guidelines (Appendix 122 A.2 and Video A.1). Our initial guidelines prioritized the public health need for social distancing, 123 recognizing that patient preference would play a more integral role in care plans after the 124 pandemic. We focused on guidelines for low-risk women, knowing that additional services could 7 be added for higher-risk patients as needed. Feedback was solicited electronically and 126 consensus was achieved in 48 hours (March 20, 2020). Principle 1: Design care around essential services We first identified critical prenatal services that could not be completed remotely: ultrasounds, 130 vaccinations, laboratory tests, and physical exams. We then grouped services based on 131 recommended timing during pregnancy (e.g., gestational diabetes screening, pertussis vaccine, Patient engagement: We recognized that many patients derive reassurance from attending 165 prenatal visits, checking their blood pressure, and listening to fetal heart tones, though these 166 services are not evidence-based. To address potential concerns, we created comprehensive 167 patient resources on the 4-1-4 prenatal plan and prenatal care during COVID-19. We also 168 designed materials on monitoring, including lists of blood pressure cuffs and dopplers available 169 for purchase and how to use these devices. Additionally, we trained 50 medical students to call 170 patients to review the new prenatal care schedule, offer connection to social services, and 171 discuss home monitoring options with them. Policy change: National policy changes, including federal allowances for telemedicine and 174 relaxation of HIPPA regulations for "good faith" use of telecommunication devices, supported 175 reimbursement of telemedicine services. 7 Additionally, we are advocating for local policy 176 changes like public and private payer reimbursement for remote monitoring devices to 9 sustainably support provision of blood pressure cuffs, scales, and fetal heart rate monitors to 178 patients based on preferences and/or medical need. As the new prenatal care pathway becomes normalized, we will monitor safety and course 181 correct as needed. Formal evaluation will include measures of maternal-infant health outcomes, 182 patient and provider satisfaction, and healthcare utilization and cost. Conclusions: The COVID-19 pandemic has forced our healthcare system to rapidly evolve. The principles 186 identified here for prenatal care redesign have broad applications beyond the pandemic. By 187 designing in-person care around critical services, maintaining connections virtually, and thinking 188 flexibly about support, we can develop tailored care pathways that best meet patients' needs. Reduced in-person contacts can free provider and health system capacity for patients who need We are long overdue for a prenatal care redesign to make services more effective, efficient, and 205 equitable. Perhaps COVID-19 is the crisis we need to advance prenatal care beyond the model 206 that has remained unchanged since 1930 and move to more flexible, patient-centered care. Outcomes/information gathered on patient/public information How the information gathered was used to inform the guideline development process and/or formation of the recommendations Report the target (or intended) users of the guideline. The intended guideline audience (e.g. specialists, family physicians, patients, clinical or institutional leaders/administrators) How the guideline may be used by its target audience (e.g., to inform clinical decisions, to inform policy, to inform standards of care) 2 Report details of the strategy used to search for evidence. Report the health benefits, side effects, and risks that were considered when formulating the recommendations. Supporting data and report of harms/side effects/risks Reporting of the balance/trade-off between benefits and harms/side effects/risks Recommendations reflect considerations of both benefits and harms/side effects/risks 1, 10-12 Describe the explicit link between the recommendations and the evidence on which they are based. How the guideline development group linked and used the evidence to inform recommendations Link between each recommendation and key evidence (text description and/or reference list) Link between recommendations and evidence summaries and/or evidence tables in the results section of the guideline 2 Report the methodology used to conduct the external review. Purpose and intent of the external review (e.g., to improve quality, gather feedback on draft recommendations, assess applicability and feasibility, disseminate evidence) Methods taken to undertake the external review (e.g., rating scale, open-ended questions) Description of the external reviewers (e.g., number, type of reviewers, affiliations) Outcomes/information gathered from the external review (e.g., summary of key findings) How the information gathered was used to inform the guideline development process and/or formation of the recommendations (e.g., guideline panel considered results of review in forming final recommendations) 2 Describe the procedure for updating the guideline. A statement that the guideline will be updated Present the key recommendations so that they are easy to identify. Recommendations in a summarized box, typed in bold, underlined, or presented as flow charts or algorithms Specific recommendations grouped together in one section 4 DOMAIN 5: APPLICABILITY Describe the facilitators and barriers to the guideline's application. Types of facilitators and barriers that were considered Methods by which information regarding the facilitators and barriers to implementing recommendations were sought (e.g., feedback from key stakeholders, pilot testing of guidelines before widespread implementation) Information/description of the types of facilitators and barriers that emerged from the inquiry (e.g., practitioners have the skills to deliver the recommended care, sufficient equipment is not available to ensure all eligible members of the population receive mammography) How the information influenced the guideline development process and/or formation of the recommendations 14 Additional materials to support the implementation of the guideline in practice. Describe any potential resource implications of applying the recommendations. Types of cost information that were considered (e.g., economic evaluations, drug acquisition costs) Methods by which the cost information was sought (e.g., a health economist was part of the guideline development panel, use of health technology assessments for specific drugs, etc.) Information/description of the cost information that emerged from the inquiry (e.g., specific drug acquisition costs per treatment course) How the information gathered was used to inform the guideline development process and/or formation of the recommendations 21. MONITORING/ AUDITING CRITERIA Provide monitoring and/or auditing criteria to measure the application of guideline recommendations. For more information about the AGREE Reporting Checklist, please visit the AGREE Enterprise website at http://www.agreetrust.org. Guidelines for Perinatal Care American Academy of Pediatrics/The American College of 211 Obstetricians and Gynecologists; 2017. 212 2. United States Department of Labor Children's Bureau. Prenatal Care A comparison of international prenatal care 215 guidelines for low-risk women to inform high-value care Alternative versus standard packages of antenatal 217 care for low-risk pregnancy Randomized comparison of a reduced-219 visit prenatal care model enhanced with remote monitoring Patient Preferences 221 for Prenatal and Postpartum Care Delivery: A Survey of Postpartum Women American College of Obstetricians and Gynecologists. COVID-19 FAQs for Obstetrician-224 COVID-19) and pregnancy: what obstetricians need to know Right-Sizing Prenatal Care to Meet Patients' 232 Needs and Improve Maternity Care Value